Efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and concomitant heart failure

被引：0
|
作者：
Kosiborod, M. [1 ]
Gause-Nilsson, I. [2 ]
Sonesson, C. [2 ]
Johnsson, E. [2 ]
机构：
[1] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[2] AstraZeneca, Molndal, Sweden
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
765
引用
收藏
页码：S368 / S368
页数：1
相关论文
共 50 条
  • [41] Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
    Dharmalingam, Mala
    Sharma, Surendra Kumar
    Prakash, Ved
    Maiti, Animesh
    Kumar, Ritesh
    Murthy, Laxminarayanappa Sreenivasa S.
    Ramanathan, Balamurugan
    Maheshwari, Sanjiv
    Kethavath, Sunil Naik
    Ogale, Dhananjay
    Bachubhai, Prajapati Vipul Kumar
    Sonawane, Ashutosh B.
    Shah, Vaishal
    Suresh, Manjula
    Chakraborty, Sisir
    Manjunath, Krishna Kumar
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [42] THE EFFICACY AND RENAL SAFETY OF SWITCHING FROM DAPAGLIFLOZIN TO EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, Ai-Yu
    Chen, Hung-Chun
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1374 - 1374
  • [43] Type 2 diabetes mellitus and heart failure
    Choy, Christine K.
    Rodgers, Jo E.
    Nappi, Jean M.
    Haines, Stuart T.
    [J]. PHARMACOTHERAPY, 2008, 28 (02): : 170 - 192
  • [44] Safety and efficacy of the SGLT2 inhibitor dapagliflozin in older patients with type 2 diabetes
    Fioretto, P.
    de Bruin, T. W.
    Johnsson, E.
    Ptaszynska, A.
    Parikh, S.
    List, J. F.
    [J]. DIABETOLOGIA, 2013, 56 : S383 - S383
  • [45] Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
    Ibrahim, Ayman
    Ghaleb, Ramadan
    Mansour, Hossam
    Hanafy, Amr
    Mahmoud, Naggeh M.
    Abdelfatah Elsharef, Mohamed
    Kamal Salama, Mohamed
    Elsaughier, Saud M.
    Abdel-Wahid, Lobna
    Embarek Mohamed, Mona
    Ibrahim, Ahmed K.
    Abdel-Galeel, Ahmed
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [46] Empagliflozin versus dapagliflozin for primary prevention of heart failure in patients with type 2 diabetes
    Arbel, R. Ronen
    Aboalhasan, E.
    Hammerman, A.
    Azuri, J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 95 - 95
  • [47] Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in China: Results from the DONATE Study
    Guo, Lixin
    Wang, Jing
    Li, Li
    Yuan, Lin
    Chen, Sheng
    Wang, Hui
    Li, Tonghuan
    Qi, Lin
    Yang, Hong
    [J]. DIABETES, 2022, 71
  • [48] Efficacy and safety of esaxerenone in patients with hypertension and concomitant heart failure
    Naruke, Takashi
    Maemura, Kenji
    Oki, Takumi
    Yazaki, Mayu
    Fujita, Teppei
    Ikeda, Yuki
    Nabeta, Takeru
    Ishii, Shunsuke
    Minami, Yoshiyasu
    Fukaya, Hidehira
    Yuge, Masaru
    Shimohama, Takao
    Kawaguchi, Takeo
    Ako, Junya
    [J]. HYPERTENSION RESEARCH, 2021, 44 (05) : 601 - 603
  • [49] Efficacy and safety of esaxerenone in patients with hypertension and concomitant heart failure
    Takashi Naruke
    Kenji Maemura
    Takumi Oki
    Mayu Yazaki
    Teppei Fujita
    Yuki Ikeda
    Takeru Nabeta
    Shunsuke Ishii
    Yoshiyasu Minami
    Hidehira Fukaya
    Masaru Yuge
    Takao Shimohama
    Takeo Kawaguchi
    Junya Ako
    [J]. Hypertension Research, 2021, 44 : 601 - 603
  • [50] Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience
    Scorsone, Alessandro
    Saura, Gabriella
    Fleres, Mattia
    Spano, Lucia
    Aiello, Vito
    Brancato, Davide
    Di Noto, Anna
    Provenzano, Francesca
    Provenzano, Vincenzo
    [J]. JOURNAL OF DIABETES RESEARCH, 2018, 2018
12345